[1]Patent:US2008/32998,2008,A1.Locationinpatent:Page/Pagecolumn20
[2]Patent:WO2011/15343,2011,A1.Locationinpatent:Page/Pagecolumn41
[3]Patent:US2019/284182,2019,A1
1005209-42-6
1353498-59-5
300717-72-0
378211-85-9
331647-95-1
832740-60-0
1007-33-6 | Cyclohexaneethanamine, N,α-dimethyl-, hydrochloride (1:1) | AA0002KP | MFCD00242814
1008-91-9 | 1-(4-Pyridyl)piperazine | AA0002UG | MFCD00040745
1009119-83-8 | 4,4'-Bis(2-((s)-pyrrolidin-2-yl)-1h-imidazol-5-yl)-1,1'-biphenyl 4hcl | AA00033P | MFCD28404675
101-79-1 | 4-Amino-4'-chlorodiphenyl ether | AA0003D4 | MFCD00043925
1011-41-2 | 2-Morpholino-1,3-thiazole-5-carbaldehyde | AA0003P0 | MFCD01568825
10129-56-3 | 4-Pyridineethanol, α-(trichloromethyl)- | AA000435 | MFCD00177920
101460-22-4 | 3-Bromo-2,5,6-trimethoxybenzoic acid | AA0004G3 | MFCD00191620
1015242-07-5 | 2-Pyrrolidinopyrimidine-5-boronic acid pinacol ester | AA0004MM | MFCD07781249
1016641-53-4 | 3-Methyl-6-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)-3h-benzooxazol-2-one | AA000515 | MFCD19689521
1017779-75-7 | 2,3,6-Trifluorobenzenesulfonyl chloride | AA0005EG | MFCD09832391